Did you miss one of our webinars? Simply select the appropriate link below and view the recorded webinar. It will not be interactive, but you will see the chat questions the original attendees asked. For additional information on the products discussed in the webinar, explore our links to videos and other resources.
If there is an area you would like to see covered, you can request a topic of your choice.
If you are experiencing issues opening the webinar recordings, please be sure that you have the latest Adobe Flash Player installed.
Tuesday, May 10, 2016
Dr. Harmjan Kuipers, Janssen Pharmaceutical, Infectious Diseases and Vaccines
This webinar will discuss the application of Promega’s ADCC reporter bioassays in influenza vaccine development with special emphasis on the setup and use and of a murine FcγRIV version of this assay.
Tuesday, April 26, 2016
Joshua Stahl, M.Sc., ArcherDx, Inc.
This webinar will detail the advantages of gene fusion detection via RNA-Seq methods and enhancements that can be gained through improvements in nucleic acid purification protocols.
Wednesday, April 20, 2016
SoftGenetics introduced themselves to the forensic DNA community by offering a new alternative in STR analysis, GeneMarker®HID. Since their initial launch, GeneMarker®HID has been gaining traction by continuously developing new advancements. Papers have already been published illustrating the software’s capabilities of generating accurate and reliable results. This webinar will focus on a user’s capabilities within the GeneMarker®HID software. The ultimate goal is to illustrate the ease of use, benefits, and additional features for a forensic DNA analyst.
Tuesday, April 12, 2016
Ulrike Herbrand, PhD, Charles River Laboratories
In past years, the requirement for bioactivity testing changed from later phase lot release and stability testing to additional applications like biocomparability testing for follow-on biologics, accelerated stress condition testing and confirmation of successful production scale up. Therefore a suitable bioassay is needed at a very early time point. This webinar will look at a wide variety of therapeutic proteins and illustrate some best practices in method development that results in reliable, reproducible and precise assays, and discuss which assays may be best for your product and development program.
Tuesday, March 22, 2016
Andrew Benjamin Nixon, PhD, MBA, Duke University School of Medicine
This webinar will explore circulating cell-free DNA workflows for biomarker discovery and downstream NGS analysis of tumor samples in a research environment.